Search for: "Eli Lilly "
Results 441 - 460
of 2,146
Sort by Relevance
|
Sort by Date
17 Jul 2017, 3:39 pm
Here as promised is the second part of this GuestKat's commentary on Eli Lilly v Actavis UK [2017] UKSC 48, which promises to have much ink spilled and air of various temperatures emitted on its behalf in the coming weeks, months and years. [read post]
15 Jul 2017, 5:11 am
The summary stated that the Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. [read post]
13 Jul 2017, 11:10 am
The Middlesex Guildhall, Site of the Supreme Court Photo Christine SmithCreative Commons Attribution Share-Alike 4.0 International LicenceSource Wikipedia Jane Lambert Supreme Court (Lords Neuberger, Mance, Clarke, Sumption and Hodge) Eli Lilly v Actavis UK Ltd and others [2017] UKSC 48 (12 July 2017) What the Appeal was about The pharmaceutical company Eli Lilly and Co (" [read post]
13 Jul 2017, 8:47 am
Thirteen years after the House of Lords had firmly shut the door on any notion of a doctrine extending the scope of patent protection outside the claims, the UK Supreme Court in yesterday’s judgment in Actavis v Eli Lilly [2017] UKSC 48 reversed gear and reintroduced a true form of doctrine of equivalents into UK law. [read post]
13 Jul 2017, 8:47 am
Thirteen years after the House of Lords had firmly shut the door on any notion of a doctrine extending the scope of patent protection outside the claims, the UK Supreme Court in yesterday’s judgment in Actavis v Eli Lilly [2017] UKSC 48 reversed gear and reintroduced a true form of doctrine of equivalents into UK law. [read post]
12 Jul 2017, 1:34 pm
It is here - the Supreme Court's decision in Eli Lilly v Actavis UK [2017] UKSC 48. [read post]
12 Jul 2017, 10:14 am
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
12 Jul 2017, 10:14 am
It will suffice to recall that the case stemmed from a complaint filed by Actavis against Eli Lilly in England seeking a declaration of non-infringement affecting not only England but also France, Italy and Spain. [read post]
12 Jul 2017, 7:59 am
Eli Lilly v Actavis UK [2017] UKSC 48This is an important case about whether drugs manufactured by Actavis infringe a European patent of Lilly. [read post]
12 Jul 2017, 2:30 am
This appeal considered whether a new pemetrexed based cancer treatment produced by Actavis UK Ltd & others infringes Eli Lilly & Co’s patent and its foreign designations either indirectly under the Patents Act 1977, s 60(2) (matter for appeal) or directly under a proper interpretation of the Europe Patent Convention 2000, art 69 (matter for cross-appeal). [read post]
10 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
7 Jul 2017, 8:53 am
Brian CorderyBy Gregory Bacon The UK Supreme Court announced this morning that it has allowed Eli Lilly’s appeal and held that Actavis’ pemetrexed products directly infringe Lilly’s European patent to pemetrexed disodium in the United Kingdom, France, Italy and Spain. [read post]
7 Jul 2017, 8:53 am
Brian CorderyBy Gregory Bacon The UK Supreme Court announced this morning that it has allowed Eli Lilly’s appeal and held that Actavis’ pemetrexed products directly infringe Lilly’s European patent to pemetrexed disodium in the United Kingdom, France, Italy and Spain. [read post]
7 Jul 2017, 4:12 am
The Eli Lilly Kat experiencing that Friday feeling....As reported on the IPKat (multiple times), the on-going saga between Eli Lilly and Actavis regarding Lilly's pemetrexed disodium product has kept the English courts busy for years. [read post]
3 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
2 Jul 2017, 12:52 am
(Eli Lilly v Novopharm (2010 FCA 197)This exercise requires:Reviewing the entire specification (claims and entire disclosure)Identifying the promises made in the entire specification Determining whether the patent fulfils those promises by demonstration or sound prediction.This exercise is a question of law viewed through the skilled person at the time of filing (with the assistance of expert evidence) and has been applied in several cases (BMS v Apotex (2005 FC 1348),… [read post]
1 Jul 2017, 9:39 am
(Eli Lilly v Novopharm (2010 FCA 197)This exercise requires:Reviewing the entire specification (claims and entire disclosure)Identifying the promises made in the entire specification Determining whether the patent fulfils those promises by demonstration or sound prediction.This exercise is a question of law viewed through the skilled person at the time of filing (with the assistance of expert evidence) and has been applied in several cases (BMS v Apotex (2005 FC 1348),… [read post]
27 Jun 2017, 5:45 pm
Eli Lilly & Co., 598 F.3d 1336, 1351(Fed. [read post]
26 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
19 Jun 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
